Free Trial
LON:SXS

Spectris (SXS) Share Price, News & Analysis

Spectris logo
GBX 2,042 +16.00 (+0.79%)
As of 04/25/2025 12:49 PM Eastern

About Spectris Stock (LON:SXS)

Key Stats

Today's Range
2,020
2,064
50-Day Range
1,909
2,952
52-Week Range
1,877
3,430
Volume
184,274 shs
Average Volume
1.44 million shs
Market Capitalization
£2.03 billion
P/E Ratio
7.56
Dividend Yield
3.97%
Price Target
GBX 3,597.50
Consensus Rating
Buy

Company Overview

The experts in providing insight through precision measurement. Our purpose is to deliver value beyond measure – going beyond just the measurement. Precision is at the heart of what we do. Spectris provides global customers with specialist insight through our high-tech instruments and test equipment, augmented by the power of our software. Through a combination of our hardware, analytical and simulation software, we provide our customers with superior data and invaluable insights that enable them to work faster, smarter and more efficiently. This equips them with the ability to reduce time to market, improve processes, quality and yield. In this way, our know-how creates value for wider society, as our customers manufacture and develop new products to make the world cleaner, healthier and more productive. Delivering value beyond measure.

Receive SXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectris and its competitors with MarketBeat's FREE daily newsletter.

SXS Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Barclays Remains a Buy on Spectris (SXS)
Spectris (SXS) Gets a Buy from Berenberg Bank
Spectris Share Chat (SXS)
See More Headlines

SXS Stock Analysis - Frequently Asked Questions

Spectris' stock was trading at GBX 2,508 at the start of the year. Since then, SXS shares have decreased by 18.6% and is now trading at GBX 2,042.
View the best growth stocks for 2025 here
.

Spectris plc (LON:SXS) issued its quarterly earnings results on Friday, February, 28th. The company reported $148.10 EPS for the quarter. Spectris had a net margin of 20.44% and a trailing twelve-month return on equity of 20.13%.
Read the conference call transcript
.

Shares of SXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Spectris investors own include Eiger BioPharmaceuticals (EIGR), Abcam (ABC), Danaher (DHR), Intel (INTC), Rotork (ROR), Tesla (TSLA) and AltaGas (ALA).

Company Calendar

Last Earnings
2/28/2025
Today
4/27/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Scientific & Technical Instruments
Sub-Industry
N/A
Current Symbol
LON:SXS
CIK
N/A
Fax
N/A
Employees
7,266
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 3,597.50
High Stock Price Target
GBX 4,250
Low Stock Price Target
GBX 2,950
Potential Upside/Downside
+76.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
7.56
Forward P/E Ratio
10.48
P/E Growth
2.74
Net Income
£270.93 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.33 billion
Cash Flow
GBX 71.63 per share
Price / Cash Flow
28.51
Book Value
GBX 1,397.02 per share
Price / Book
1.46

Miscellaneous

Free Float
N/A
Market Cap
£2.03 billion
Optionable
Not Optionable
Beta
0.61
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (LON:SXS) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners